IFNG and neoplasm: IFNγ reprograms TAMs into a tumoricidal (M1) phenotype [30,31], and promotes anti-tumor T-cell responses, inducing tumor-specific T cell memory [32], facilitating the differentiation of Th1 cells, and inhibiting the expression of exhaustion marker PD-1 on CD8+T cells [33].